Search research articles
Contact Us
Filters
Showing results (91-100 of 114) with videos related to
Page
of 12
Sort By:
Molecular Genetics and Metabolism
|
November 23, 2024
The effects of casein glycomacropeptide on general health status in children with PKU: A randomized crossover trial
Alex Pinto, Anne Daly, Camille Newby, et al.
Molecular Genetics and Metabolism
|
March 18, 2025
Corrigendum to "The effects of casein glycomacropeptide on general health status in children with PKU: A randomized crossover trial" [Molecular Genetics and Metabolism Volume 143, Issue 4, December 2024, 108607]
Alex Pinto, Anne Daly, Camille Newby, et al.
Nutrients
|
December 23, 2023
Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria
Luis M Luengo-Pérez, Mercedes Fernández-Bueso, Ana Ambrojo, et al.
Nutrients
|
July 2, 2021
A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes
Anne Daly, Wolfgang Högler, Nicola Crabtree, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 1, 2017
The discovery of fluazaindolizine: A new product for the control of plant parasitic nematodes
George P Lahm, Johan Desaeger, Ben K Smith, et al.
Journal of Inherited Metabolic Disease
|
November 25, 2017
Daily variation of NTBC and its relation to succinylacetone in tyrosinemia type 1 patients comparing a single dose to two doses a day
Nienke S Kienstra, Hannah E van Reemst, Willem G van Ginkel, et al.
Nutrients
|
February 13, 2026
Global Use of Casein Glycomacropeptide Protein Substitutes for Phenylketonuria (PKU): Health Professional Perspectives
Sharon Evans, Rani Singh, Kirsten Ahring, et al.
Orphanet Journal of Rare Diseases
|
July 1, 2016
Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls
Willem G van Ginkel, Rianne Jahja, Stephan C J Huijbregts, et al.
Nutrients
|
August 26, 2023
Evaluation of a New 'Mix-In' Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia
Marta Delsoglio, Rebecca Capener, Anita MacDonald, et al.
Nutrients
|
August 26, 2023
Evaluation of a New Glycomacropeptide-Based Protein Substitute in Powdered and Liquid Format in Patients with PKU
Marta Delsoglio, Rebecca Capener, Anita MacDonald, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 114) with videos related to
Sort By:
Page
of 12
Molecular Genetics and Metabolism
|
November 23, 2024
The effects of casein glycomacropeptide on general health status in children with PKU: A randomized crossover trial
Alex Pinto, Anne Daly, Camille Newby, et al.
Molecular Genetics and Metabolism
|
March 18, 2025
Corrigendum to "The effects of casein glycomacropeptide on general health status in children with PKU: A randomized crossover trial" [Molecular Genetics and Metabolism Volume 143, Issue 4, December 2024, 108607]
Alex Pinto, Anne Daly, Camille Newby, et al.
Nutrients
|
December 23, 2023
Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria
Luis M Luengo-Pérez, Mercedes Fernández-Bueso, Ana Ambrojo, et al.
Nutrients
|
July 2, 2021
A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes
Anne Daly, Wolfgang Högler, Nicola Crabtree, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 1, 2017
The discovery of fluazaindolizine: A new product for the control of plant parasitic nematodes
George P Lahm, Johan Desaeger, Ben K Smith, et al.
Journal of Inherited Metabolic Disease
|
November 25, 2017
Daily variation of NTBC and its relation to succinylacetone in tyrosinemia type 1 patients comparing a single dose to two doses a day
Nienke S Kienstra, Hannah E van Reemst, Willem G van Ginkel, et al.
Nutrients
|
February 13, 2026
Global Use of Casein Glycomacropeptide Protein Substitutes for Phenylketonuria (PKU): Health Professional Perspectives
Sharon Evans, Rani Singh, Kirsten Ahring, et al.
Orphanet Journal of Rare Diseases
|
July 1, 2016
Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls
Willem G van Ginkel, Rianne Jahja, Stephan C J Huijbregts, et al.
Nutrients
|
August 26, 2023
Evaluation of a New 'Mix-In' Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia
Marta Delsoglio, Rebecca Capener, Anita MacDonald, et al.
Nutrients
|
August 26, 2023
Evaluation of a New Glycomacropeptide-Based Protein Substitute in Powdered and Liquid Format in Patients with PKU
Marta Delsoglio, Rebecca Capener, Anita MacDonald, et al.
Page
of 12